Quarterly report pursuant to Section 13 or 15(d)

Revenues from Contracts and Significant Customers (Narrative) (Details)

v3.23.1
Revenues from Contracts and Significant Customers (Narrative) (Details) - Dermatology Products Sales - Customer Concentration Risk - customer
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Revenue [Member]    
Disaggregation of Revenue [Line Items]    
Number of customers 0  
Accounts Receivable [Member]    
Disaggregation of Revenue [Line Items]    
Number of customers 1 1
Customer one | Accounts Receivable [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 13.70%  
Customer Two | Accounts Receivable [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 16.70% 10.40%